Last reviewed · How we verify
Intra venous fluid
Intra venous fluid is a Small molecule drug developed by King's College London. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Intra venous fluid |
|---|---|
| Sponsor | King's College London |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- EARLY-PREG: A Preconception Cohort Study Based on Counterfactuals to Study Maternal-Embryonic Molecular Interactions
- Continuous Spinal Anesthesia in Renal Transplantation (NA)
- Venous Congestion And Delirium After Cardiac Surgery
- Intraosseous Infusion in Hematologic Critical Patients
- Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury
- Free Amino-acid Composition of Peri-implant and Periodontal Conditions
- Hepatic Blood Flow Changes During Fluid Challenge Assessed by MRI in Volunteers Subjects. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra venous fluid CI brief — competitive landscape report
- Intra venous fluid updates RSS · CI watch RSS
- King's College London portfolio CI
Frequently asked questions about Intra venous fluid
What is Intra venous fluid?
Who makes Intra venous fluid?
What development phase is Intra venous fluid in?
Related
- Manufacturer: King's College London — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing